Tag:
Vacc-C5
Latest Headlines
Latest Headlines
Bionor's new HIV vaccine moves into clinical trials
Bionor's latest HIV vaccine, Vacc-C5, is ready to go into therapeutic clinical trials at Oslo University Hospital.
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Press Releases
- To Help Counter Record-High Levels of Cargo Theft, Chubb Adds Covert Shipment Tracking to Suite of Security Services
- ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
- The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial
- Biomet Announces Initial Closing of DePuy Trauma Acquisition
- KCI Announces FDA 510(k) Clearance of V.A.C. Therapy for Management of Closed Surgical Incisions
- More Press Releases
Featured Jobs
-
Senior Engineer, Project Job
Celgene Corporation - Phoenix, AZ, US -
Director, Regulatory Affairs
Tesaro - Waltham, MA -
Forecasting/Analytics Manager
Sucampo Pharmaceuticals - Washington, DC -
Scientist Job
Yoh - Emeryville, CA, USA -
Senior Manager, API Development
TESARO - Waltham, MA